Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane plus S-1 in advanced gastric cancer
NCT02229058Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2012
- Primary completion
- Feb 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of nab-paclitaxel in gastric cancer (GC), sponsored by Sun Yat-sen University. Primary endpoint: Progression-Free Survival at 2 years. Started Feb 2012; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02229058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229058.